ArticleIntensive care medicine2007
Health technology assessment in critical care.
Article in Intensive care medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Retrospective Evaluation of the Epidemiology and Practice Variation of Dexmedetomidine Use in Invasively Ventilated Pediatric Intensive Care Admissions, 2007-2013.Frontiers in pediatrics · 2015Article
- Economics of ICU organization and management.Critical care clinics · 2012Review
- Year in review in Intensive Care Medicine, 2007. III. Ethics and legislation, health services research, pharmacology and toxicology, nutrition and paediatrics.Intensive care medicine · 2008Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeath technology assessments (HTAs) evaluate the benefits and costs of devices for monitoring and therapy (and their associated requirements for human resources) which contribute to the high expense associated with ICU admission. DISCUSSION: Given the limited resources available for health care and increasing demands, funds spent inefficiently or unnecessarily on technologies in the ICU may threaten the sustainability of the health care system or prevent other potentially cost-effective devices from being introduced into clinical care. We discuss the factors impeding the conducting of HTAs in the ICU and suggest strategies for change.
conclusionsDespite the need for HTAs of ICU devices only few have been conducted. They should be undertaken more frequently, and their results used to influence clinical practice and hospital and regional-level policy decisions.
Indexed as
Identifiers
17952404What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.